Therapixel announces launch of prospective study on the utility of Artificial Intelligence (AI) as part of second reading breast cancer screening mammograms

The first French prospective clinical study to evaluate the contribution of AI in the second reading of screening mammograms.

0 Comments8 Minutes

Therapixel releases a new version of MammoScreen® that leverages prior exams for better accuracy

For the first time, an AI-based decision support software for breast cancer detection uses patient’s prior exams to refine its prediction of malignancy

0 Comments4 Minutes

Therapixel announces close of 15 M€ series B financing to deploy MammoScreen® 2D/3D

The Company will accelerate the commercial deployment of its Artificial Intelligence reading solution for 2D/3D mammography, with a focus on the United States

0 Comments11 Minutes

Therapixel receives FDA clearance for use of its AI-based breast cancer screening software MammoScreen® on Digital Breast Tomosynthesis

AI-powered reading aid for screening 2D & 3D mammography improves Radiologists’ performance in cancer detection

0 Comments4 Minutes

Therapixel will be showcasing MammoScreen™ at the virtual ECR 2021

Stop by our booth to learn more about our FDA-cleared and newly CE-marked AI for breast cancer screening

0 Comments1 Minutes

Therapixel receives the CE mark for its Artificial Intelligence-based software (AI) MammoScreen™

This cutting-edge technology assists radiologists in the interpretation of screening mammograms and allows them to diagnose breast cancer earlier and more accurately.

0 Comments3 Minutes

Therapixel and RAD-AID International Announce Breast Imaging AI Collaboration for Global Health

The collaboration donates and supports AI for making breast cancer screening more accessible and available in impoverished regions of the world

0 Comments5 Minutes

Therapixel participates in the Journées Francophones de Radiologie 2020

Experience the Award-winning MammoScreen™ at our virtual booth on the online platform

0 Comments2 Minutes

Therapixel is now ISO/IEC 27001 certified

Our information security management system is compliant with the world gold standard, ensuring a high level of cybersecurity.

0 Comments2 Minutes

Therapixel receives FDA 510(k) clearance for MammoScreen™

AI-powered reading aid for screening mammography improves Radiologists’ performance in cancer detection

0 Comments3 Minutes